Table 2 Correlation of SALL4 and HIWI genes expression with clinicopathological features of the patients
Factors | Number % | HIWI | SALL4 | P value | |||
|---|---|---|---|---|---|---|---|
Normal/Under | Overexpression | Normal/Under | Overexpression | ||||
Sex | Female | 20 (43.5) | 14 | 6 | 2 | 18 | 0.354 |
Male | 26 (56.5) | 16 | 10 | 4 | 22 | ||
Tumor location | Proximal | 13 (28.3) | 8 | 5 | 2 | 11 | 0.124 |
Distal | 33 (71.7) | 22 | 11 | 4 | 29 | ||
Grade of differentiation | WD | 29 (63) | 19 | 10 | 4 | 25 | 0.004* |
MD | 16 (43.8) | 10 | 6 | 1 | 15 | ||
PD | 1 (2.2) | 1 | 0 | 1 | 0 | ||
Depth of invasion | T1,2 | 8 (17.4) | 3 | 5 | 0 | 8 | 0.031* |
T3,4 | 38 (82.6) | 27 | 11 | 6 | 32 | ||
Lymph node metastasis | N0 | 33 (71.7) | 23 | 10 | 5 | 28 | 0.050* |
N1 | 9 (19.6) | 4 | 5 | 0 | 9 | ||
N2 | 4 (8.7) | 3 | 1 | 1 | 3 | ||
Stage of progression | I/II | 34 (73.9) | 23 | 11 | 2 | 29 | 0.362 |
III/IV | 12 (26.1) | 7 | 5 | 1 | 4 | ||